(Q44122718)

30 November 2017

title

Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients (English)

1 reference

30 November 2017

0 references

fluticasone propionate

1 reference

1 reference

2

1 reference

30 November 2017

Hanifin J

1

1 reference

30 November 2017

Rajagopalan R

series ordinal

3

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 September 2002

1 reference

British Journal of Dermatology

30 November 2017

published in

1 reference

30 November 2017

volume

147

1 reference

30 November 2017

issue

3

1 reference

30 November 2017

page(s)

528-537

1 reference

The relation of stress and family environment to atopic dermatitis symptoms in children

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

The occurrence of atopic dermatitis in north Europe: an international questionnaire study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Prevalence of childhood and adolescent atopic dermatitis in a Japanese population: comparison with the disease frequency examined 20 years ago.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

The prevalence of atopic dermatitis in Oregon schoolchildren

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

The prevalence of childhood atopic eczema in a general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Practical management of atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Managing pediatric atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Update on therapy of atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

The management of moderate to severe atopic dermatitis in adults with topical fluticasone propionate. The Netherlands Adult Atopic DermatitisStudy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Topical fluticasone propionate: a review of its pharmacological properties and therapeutic use in the treatment of dermatological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Topical corticosteroid phobia in patients with atopic eczema

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

An open study of efficacy and safety of long-term treatment with mometasone furoate fatty cream in the treatment of adult patients with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

Safety of fluticasone propionate cream 0.05% for the treatment of severe and extensive atopic dermatitis in children as young as 3 months

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2133.2002.05006.X

10.1046/J.1365-2133.2002.05006.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference